Sino Biopharmaceutical Limited (SBMFF) - Total Liabilities

Latest total liabilities as of June 2025: $29.12 Billion USD

Based on the latest financial reports, Sino Biopharmaceutical Limited (SBMFF) has total liabilities worth $29.12 Billion USD as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sino Biopharmaceutical Limited - Total Liabilities Trend (1999–2024)

This chart illustrates how Sino Biopharmaceutical Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Sino Biopharmaceutical Limited Competitors by Total Liabilities

The table below lists competitors of Sino Biopharmaceutical Limited ranked by their total liabilities.

Liability Composition Analysis (1999–2024)

This chart breaks down Sino Biopharmaceutical Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sino Biopharmaceutical Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sino Biopharmaceutical Limited (1999–2024)

The table below shows the annual total liabilities of Sino Biopharmaceutical Limited from 1999 to 2024.